Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
  1. 4 Open-market sale President and CEO sold 6,500 shares at an average $44.74 ($290,779)
  2. 4 Open-market sale Chief Financial Officer sold 252 shares at $50.04 ($12,610)
  3. 4 Open-market sale Chief Oper. & Tech. Officer sold 13,312 shares at an average $50.01 ($665,767)
  4. 4 Open-market sale Chief Financial Officer sold 15,293 shares at an average $50.02 ($765,025)
  5. 4 Open-market sale Chief Legal Officer sold 21,500 shares at an average $48.14 ($1,035,082)
  6. 4 Open-market sale Chief Oper. & Tech. Officer sold 5,185 shares at $50.01 ($259,302)
  7. 4 Open-market sale Chief Financial Officer sold 16,239 shares at an average $49.06 ($796,615)
  8. 4 Open-market sale President and CEO sold 1,500 shares at $50.01 ($75,015)
  9. 4 Grant or award Chief Financial Officer acquired 12,400 shares (grant or award)
  10. 4 Grant or award Chief Oper. & Tech. Officer acquired 13,800 shares (grant or award)
  11. 4 Grant or award Chief Medical Officer acquired 11,000 shares (grant or award)
  12. 4 Grant or award Chief Scientific Officer acquired 12,543 shares (grant or award)
  13. 4 Grant or award Chief Legal Officer acquired 13,800 shares (grant or award)
  14. 4 Grant or award President and CEO acquired 40,984 shares (grant or award)
  15. 4 Open-market sale President and CEO sold 6,500 shares at an average $48.67 ($316,334)
  16. 4 Open-market sale Chief Financial Officer sold 24,500 shares at an average $50.01 ($1,225,211)
  17. 4 Open-market sale President and CEO sold 4,500 shares at $50.00 ($225,000)
  18. 4 Open-market sale President and CEO sold 15,000 shares at $45.00 ($675,000)
  19. 4 Open-market sale Chief Financial Officer sold 37,500 shares at an average $40.10 ($1,503,891)
  20. 4 Open-market sale President and CEO sold 4,500 shares at $40.00 ($180,000)

Page 9 of 22 · 435 filings